Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00428142What this trial is testingBortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma NCIC Clinical Trials Group 95
Early research (Phase 1)Study completedNCT00005580What this trial is testingBryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880What this trial is testingAgatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)Looking for participantsNCT06471738What this trial is testingCombination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular LymphomaWho this might be right forAnn Arbor Stage II Follicular LymphomaGrade 1 Follicular LymphomaAnn Arbor Stage III Follicular Lymphoma+3 more Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01116232What this trial is testingSirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Barbara Ann Karmanos Cancer Institute 4
Early research (Phase 1)Study completedNCT00891072What this trial is testingGossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaContiguous Stage II Adult Burkitt Lymphoma+78 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT03010358What this trial is testingEntospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin LymphomaWho this might be right forAnemiaB-Cell Prolymphocytic LeukemiaGrade 1 Follicular Lymphoma+11 more Alexey Danilov, MD 24
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT03583424What this trial is testingVenetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forHematopoietic Cell Transplantation RecipientRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+9 more Ohio State University Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00989586What this trial is testingVeltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Beth Christian 35
Testing effectiveness (Phase 2)Ended earlyNCT01307605What this trial is testingRituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular LymphomaWho this might be right forLymphoma Swiss Cancer Institute 154
Testing effectiveness (Phase 2)Study completedNCT00026182What this trial is testingRituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Large-scale testing (Phase 3)Study completedNCT00005590What this trial is testingLevofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT00132015What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Institutes of Health Clinical Center (CC) 37